Scarica l'app Stockscreener
21.63
1.93%
0.41
Dopo l'orario di chiusura:
22.00
0.37
+1.71%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TNGX Giù?
Forum
Previsione
Precedente Chiudi:
$21.22
Aprire:
$21.26
Volume 24 ore:
2.91M
Relative Volume:
0.86
Capitalizzazione di mercato:
$3.09B
Reddito:
$62.38M
Utile/perdita netta:
$-101.59M
Rapporto P/E:
-25.02
EPS:
-0.8644
Flusso di cassa netto:
$-139.93M
1 W Prestazione:
+8.91%
1M Prestazione:
+87.60%
6M Prestazione:
+181.27%
1 anno Prestazione:
+1,479%
Intervallo 1D:
$20.62
$22.20
Intervallo di 1 settimana:
$18.93
$22.20
Portata 52W:
$1.03
$22.20
Tango Therapeutics Inc Stock (TNGX) Company Profile
Nome
Tango Therapeutics Inc
Settore
Industria
Telefono
(857) 320-4900
Indirizzo
201 BROOKLINE AVENUE, BOSTON
Compare TNGX vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
21.63 | 3.09B | 62.38M | -101.59M | -139.93M | -0.8644 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-23 | Iniziato | Mizuho | Outperform |
| 2025-11-18 | Iniziato | Wolfe Research | Peer Perform |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2024-07-17 | Iniziato | Jefferies | Buy |
| 2024-04-04 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-12 | Iniziato | Piper Sandler | Overweight |
| 2023-12-08 | Iniziato | B. Riley Securities | Buy |
| 2022-10-20 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2021-09-20 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Tango Therapeutics Inc Borsa (TNGX) Ultime notizie
Tango Therapeutics is the best performing healthcare stock in March - MSN
Canaccord Genuity initiates coverage of Tango Therapeutics (TNGX) with buy recommendation - MSN
Insider Selling: Tango Therapeutics (NASDAQ:TNGX) Insider Sells 27,000 Shares of Stock - MarketBeat
Tango Therapeutics stock hits all-time high at 21.84 USD By Investing.com - Investing.com Canada
Tango Therapeutics president sells $572k in shares By Investing.com - Investing.com Canada
Tango Therapeutics (NASDAQ: TNGX) president sells 27,000 shares - Stock Titan
Tango a new Buy at Canaccord Genuity on 2026 catalysts - MSN
Tango stock is a new Buy at Canaccord Genuity (TNGX:NASDAQ) - seekingalpha.com
Tango Therapeutics (NASDAQ:TNGX) Reaches New 12-Month HighHere's Why - MarketBeat
TNGX Should I Buy - intellectia.ai
Canaccord Genuity Group Begins Coverage on Tango Therapeutics (NASDAQ:TNGX) - MarketBeat
CCORF Initiates Tango Therapeutics(TNGX.US) With Buy Rating, Announces Target Price $30 - Moomoo
Tudor Investment Corp ET AL Takes $450,000 Position in Tango Therapeutics, Inc. $TNGX - MarketBeat
Is Tango Therapeutics Inc a strong candidate for buy and hold2026 Chart Watch & AI Based Trade Execution Alerts - baoquankhu1.vn
Decliners Report: Can Tango Therapeutics Inc be recession proof2026 Fed Impact & Free Reliable Trade Execution Plans - baoquankhu1.vn
Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
TNGX Stock Price, Quote & Chart | TANGO THERAPEUTICS INC (NASDAQ:TNGX) - ChartMill
Tango Therapeutics (TNGX) price target increased by 32.09% to 20.06 - MSN
Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge - AOL.com
Tango Therapeutics is the best performing healthcare stock in March (XLV:NYSEARCA) - Seeking Alpha
Evaluating Tango Therapeutics (TNGX) Rich Valuation After Recent Share Price Momentum - finance.yahoo.com
Geopolitics Watch: Can Tango Therapeutics Inc ride the EV waveTrade Performance Summary & Community Verified Trade Alerts - baoquankhu1.vn
Adam Crystal Sells 12,000 Shares of Tango Therapeutics (NASDAQ:TNGX) Stock - MarketBeat
VIX Spike: Is Tango Therapeutics Inc a strong candidate for buy and holdSwing Trade & Risk Managed Investment Signals - baoquankhu1.vn
Tango Therapeutics president sells $241k in shares By Investing.com - Investing.com South Africa
Tango Therapeutics president sells $241k in shares - Investing.com
Tango Therapeutics (TNGX) R&D chief exercises options, sells 12,000 shares - stocktitan.net
Momentum Shift: Is Tango Therapeutics Inc stock good for income investors2026 Volume & Consistent Profit Alerts - baoquankhu1.vn
TNGXTango Therapeutics Inc Stock Price and Quote - Finviz
Tango Therapeutics (NASDAQ: TNGX) — Vanguard reports 0 shares after realignment - Stock Titan
B. Riley Securities Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Raises Target Price to $21 - Moomoo
B. Riley Raises Price Target on Tango Therapeutics to $21 From $14, Keeps Buy Rating - MarketScreener
This Stock Is Up 1,229% in Just the Past Year, But Don’t Bet Your Retirement Money on It - inkl
TNGX: 93,000 shares from option exercise; Adam Crystal prior 10b5-1 sales (TNGX) - Stock Titan
Tango Therapeutics (NASDAQ:TNGX) Stock Price Up 9.3%Still a Buy? - marketbeat.com
Tango Therapeutics Ignites: 11% Surge to Historic Highs Signals Biotech Power Play - Bitget
TNGX stock hits record high on inking collaboration deal with ERAS - MSN
Tango Therapeutics stock hits all-time high at 19.83 USD By Investing.com - Investing.com Canada
Tango Therapeutics stock hits all-time high at 19.83 USD - Investing.com
Tango Therapeutics (TNGX) to Release Quarterly Earnings on Monday - marketbeat.com
Tango Therapeutics, Inc. (TNGX) Tops Q3 Earnings and Revenue Estimates - MSN
Trading Recap: How does Tango Therapeutics Inc correlate with Nasdaq2026 Analyst Calls & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):